Ready to contact us for a consultation about your condition and our medical services? The staff of our Global Patient Services is ready to help. Please select the appropriate button to get started.

New at Sheba: An AI Gastroenterological Cancer Diagnostic System

AI Gastroenterological Cancer Diagnostic System
The new system is expected to increase polyp detection rates by 30%

Colorectal cancer is a malignancy that begins either in the colon, the final part of the digestive tract, or the rectum. Colorectal cancer typically affects older adults, though it can occur at any age and usually begins as small, noncancerous (benign) clumps of cells called polyps that form inside the colon. Over time, some of these polyps can develop into colorectal cancers.

Polyps may be small and produce few, if any, symptoms. Consequently, regular screening tests are recommended to help prevent cancer by identifying and removing polyps before they turn cancerous.

For the first time at Sheba Medical Center, an artificial intelligence diagnostic system has been integrated into the clinical activities of the Gastroenterology Institute, raising the accuracy of early-stage colorectal cancer diagnosis with improved polyp detection.

The system works by analyzing the video feed of a colonoscopy and identifying, through the use of an advanced algorithm, polyps within a few milliseconds as they appear. After the system detects polyps, they are marked with a square on the screen monitored by a physician, reducing the likelihood of missing polyps by approximately 30%.

“During a colonoscopy, we locate and remove polyps, an action which lowers colorectal cancer mortality by about 60%, particularly in the case of distal colorectal cancer,” explains Dr. Idan Levi, an expert physician at the Gastroenterology Institute and Head of the Endoscopic Innovation Service at Sheba.

According to Dr. Levi, “The system might well decrease colorectal cancer rates among those tested by it.”

For his part, Prof. Shomron Ben-Horin, Director of the Gastroenterology Institute at Sheba, added: “All future colonoscopies at Sheba will make use of AI. However, the final decision regarding the removal of a polyp will remain at the doctor’s discretion – the system simply helps him to reach an accurate diagnosis.”

Sheba DUNS 100

For The Second Consecutive Year: Sheba Tops the Healthcare Sector on Dun & Bradstreet’s List of Leading Organizations

Dun & Bradstreet, the world’s foremost commercial data company, ranked 71 doctors from Sheba Medical Center in its list of the top Israeli clinical experts.…
Read More

Ayelet’s Miracle: The First Woman to Conceive Four Children Following Ovarian Tissue Cryopreservation

At 21, Ayelet Rozenberg was diagnosed with Hodgkin’s lymphoma. Facing aggressive therapies necessary to save her life, Ayelet feared she would never be able to…
Read More
bowel disease
News Sep 07.

Sheba Partners with Biomica to Advance Inflammatory Bowel Disease Care

As part of the new collaboration, Sheba and Biomica will engage in joint microbiome clinical research to develop better treatments for inflammatory bowel disease (IBD)…
Read More